コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 illosis, and immunodeficiency syndromes (eg, common variable immunodeficiency).
2 fferentiation in familial IgA deficiency and common variable immunodeficiency.
3 morbidity and mortality among patients with common variable immunodeficiency.
4 iency (PAD) and in about 2% of patients with common variable immunodeficiency.
5 est risk was associated with T-cell PIDs and common variable immunodeficiency.
6 responses are impaired in most patients with common variable immunodeficiency.
7 ession is similarly decreased in humans with common variable immunodeficiency.
8 ere, primary immunodeficiency reminiscent of common variable immunodeficiency.
9 ment similar to those found in patients with common variable immunodeficiency.
10 phoproliferative disease and severe cases of common variable immunodeficiency.
11 efects in patients previously diagnosed with common variable immunodeficiency.
12 ar antibodies, sinopulmonary infections, and common variable immunodeficiency.
13 ve been found to be mutated in patients with common variable immunodeficiency.
14 rom a poliomyelitis patient from Taiwan with common variable immunodeficiency.
16 tions in LRBA Biallelic LRBA mutations cause common variable immunodeficiency-8; however, NDM has not
17 was highly similar to that of patients with common variable immunodeficiency and a defect in B-cell
18 ilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in hum
19 in SEC61A1 were reported to be pathogenic in common variable immunodeficiency and glomerulocystic kid
20 on, shown through the study of patients with common variable immunodeficiency and hyper IgM syndrome,
21 ustrate the heterogeneous molecular basis of common variable immunodeficiency and indicate the value
22 ar-old woman with a presumptive diagnosis of common variable immunodeficiency and livedo reticularis
23 is review discusses the latest insights into common variable immunodeficiency and uses common variabl
24 everal primary immunodeficiencies, including common variable immunodeficiency and Wiskott-Aldrich syn
26 and additional family members suffering from common variable immunodeficiency and/or selective IgA de
27 n a clinical picture that is consistent with common variable immunodeficiency, and as many as 10% of
28 orders such as systemic lupus erythematosus, common variable immunodeficiency, and autoimmune lymphop
29 to common variable immunodeficiency and uses common variable immunodeficiency as a model to examine t
31 r other causes of villous atrophy, including common variable immunodeficiency, autoimmune enteropathy
34 ound that 4 of 19 unrelated individuals with common variable immunodeficiency (CVID) and 1 of 16 indi
36 rial translocation is a shared phenomenon in common variable immunodeficiency (CVID) and X-linked aga
40 ma cells, and almost 10% of individuals with common variable immunodeficiency (CVID) express either t
41 gG antibodies in a subgroup of patients with common variable immunodeficiency (CVID) following messen
67 e genetic causes of immune deficiency in 235 common variable immunodeficiency (CVID) patients seen in
68 in patients with autoimmune diseases and in common variable immunodeficiency (CVID) patients who are
72 der, several research groups have identified common variable immunodeficiency (CVID) subjects with nu
74 isotype-switched antibodies in patients with common variable immunodeficiency (CVID) suggests germina
75 the HVR of control patients to patients with common variable immunodeficiency (CVID) where the effect
77 rom 139 patients with PADs, 61 patients with common variable immunodeficiency (CVID), 68 patients wit
78 arisons between patients with GS, those with common variable immunodeficiency (CVID), and those with
79 fe-threatening complication in patients with common variable immunodeficiency (CVID), but the optimal
80 greatest cause of morbidity and mortality in common variable immunodeficiency (CVID), but their patho
82 ts with multilineage cytopenias secondary to common variable immunodeficiency (CVID), Evans syndrome
83 al profile of CD4 T cells from patients with common variable immunodeficiency (CVID), including produ
96 d, multicenter study, 505 patients with IEI (common variable immunodeficiency [CVID], isolated or und
97 frequent cause of morbidity and mortality in common variable immunodeficiencies (CVIDs); however, lun
100 le nucleotide polymorphisms in patients with common variable immunodeficiency disorder (CVID), which
102 mplex polygenic disorders, most commonly the common variable immunodeficiency disorders (CVIDs), pred
105 gous mutations in NFKB1 were associated with common variable immunodeficiency, however, homozygous mu
106 ysis of the proportion of any combination of common variable immunodeficiency, IgG deficiency, IgA de
107 -telangiectasia, Nijmegen-breakage-syndrome, common variable immunodeficiency, immunoglobulin A defic
109 rmore, mutations in IKZF1 are known to cause common variable immunodeficiency in patients characteriz
112 s human PRKCD deficiency as a novel cause of common variable immunodeficiency-like B-cell deficiency
114 tion, dedicator of cytokinesis 8 deficiency, common variable immunodeficiency, neutropenia, and immun
115 e defects affect a minority of patients with common variable immunodeficiency only, future genetic re
116 predominantly antibody deficiency other than common variable immunodeficiency or agammaglobulinemia.
117 native classification of patients fulfilling common variable immunodeficiency or Evans syndrome crite
118 some children currently classified as having common variable immunodeficiency or Evans syndrome.
119 tterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection a
120 nostic categories such as ALPS-like disease, common variable immunodeficiency, or Evans syndrome have
121 Using these assays, we could categorize common variable immunodeficiency patients into subgroups
122 children <2 y, the asplenic, and a subset of common variable immunodeficiency patients, are profoundl
123 rated IRF4 to be deregulated in B cells from common variable immunodeficiency patients, contributing
127 tic assessment in paediatric patients with a common variable immunodeficiency phenotype, to establish
131 Newly identified disease genes within the common variable immunodeficiency population, have advanc
133 present the different clinical phenotypes of common variable immunodeficiency, review recent genetic
134 ith unusually frequent bacterial infections, common variable immunodeficiency should always be consid
135 day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in a
136 t poliovirus infection in an individual with common variable immunodeficiency, using oral immunoglobu
137 ional features not typically associated with common variable immunodeficiency were diagnosed only lat
139 nted with a phenotype resembling early-onset common variable immunodeficiency, while extra-immunologi
141 hich was previously implicated as a cause of common variable immunodeficiency with autoimmunity.
142 the diagnosis and treatment of patients with common variable immunodeficiency, with suggestions for t